Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Adverse Drug Reaction
100%
Clopidogrel
83%
Pharmacological Analysis
69%
Peripheral Neuropathy
68%
Neurotropic B Vitamins
67%
Next-generation Sequencing
60%
Platelet Reactivity
54%
Colombian Patients
54%
Phenytoin
54%
Pharmacogenomics
51%
B Vitamins
49%
Acute Coronary Syndrome
47%
Pyridoxine
47%
Thiamine
47%
Narrative Review
43%
CYP2C19
43%
High On-treatment Platelet Reactivity
40%
Vitamin B1
39%
Warfarin
39%
Nervous System
39%
CYP2C9
36%
Self-medication
36%
Colombia
36%
Vitamin B12
33%
Neurotoxicity
33%
Polymorphism
32%
Clinical Application
31%
Potential Therapeutics
31%
Cobalamin
30%
Pathophysiology
30%
Antiepileptic Drugs
30%
Vitamin B6
29%
Latin American
29%
Colombians
28%
Population Genetics
27%
Genetic Approach
27%
Bench to Bedside
27%
Rhabdomyolysis
27%
Rosuvastatin
27%
GLP-1 Analogue
27%
Glucagon-like
27%
Warfarin Pharmacogenetics
27%
COVID-19
27%
A1 Receptor
27%
Molecular Aspects
27%
Receptor Agonist
27%
Inappropriate Use
27%
Mixed Pain
27%
Pharmacogenetics
25%
Inter-individual Variability
25%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Drug Reaction
82%
Pharmacogenetics
59%
Warfarin
47%
Adverse Event
41%
Phenytoin
40%
CYP2C9
36%
Acute Coronary Syndrome
33%
Anticonvulsive Agent
29%
Glucagon-Like Peptide-1
27%
Glucagon Like Peptide 1 Receptor Agonist
27%
Clopidogrel
27%
Self-Medication
27%
Pathophysiology
27%
CYP2C19
25%
Diseases
23%
Pharmacokinetic
21%
Neuropathy
20%
Medication Error
20%
Syndrome
20%
Vitamin B12
18%
Inflammation
16%
Pharmacogenomics
16%
Pharmacodynamics
16%
Cognitive Defect
16%
Pharmacovigilance
15%
Cross-Sectional Study
15%
Thiamine
14%
Stevens Johnson Syndrome
13%
Diclofenac
13%
Pyridoxine Plus Thiamine
13%
Clinical Research
13%
Rosuvastatin
13%
Rhabdomyolysis
13%
Lung Embolism
13%
Thromboembolism
13%
Narcotic Antagonist
13%
Pyridoxine
13%
Diphenhydramine
13%
Cortical Dysplasia
13%
Depressive Psychosis
13%
Psychotropic Agent
13%
Mood Disorder
13%
Antiarrhythmic Agent
13%
Propafenone
13%
QT Prolongation
13%
Long QT Syndrome
13%
Therapeutic Drug Monitoring
13%
Kounis Syndrome
13%
Ciprofloxacin
13%
Excitotoxicity
13%
Medicine and Dentistry
Neuropathy
65%
Cyanocobalamin
49%
Thiamine
32%
Pyridoxine
27%
Self-Medication
27%
Glucagon-Like Peptide-1 Agonist
27%
Glucagon Like Peptide 1
27%
COVID-19
27%
Anticonvulsant
27%
Clinician
24%
Nervous System
21%
Diseases
18%
Pathophysiology
18%
Clinical Trial
18%
Diabetic Neuropathy
18%
Meta-Analysis
18%
Health Care Cost
18%
Systematic Review
18%
Cobalamin
16%
Pyridoxine Plus Thiamine
16%
Pharmacogenomics
16%
Peripheral Nervous System
16%
Alzheimer's Disease
16%
Early Diagnosis
13%
Excitotoxicity
13%
Phenytoin
13%
Diclofenac
13%
Endurance Training
13%
Immune-Related Adverse Events
13%
Addictive Behavior
13%
Sensation of Pain
13%
Resistance Training
13%
Relative Risk Reduction
13%
Heart Rate Variability
13%
Treatment of Alzheimer's Disease
13%
Umbrella Review
13%
Long QT Syndrome
13%
QT Prolongation
13%
Proton-Pump Inhibitor
13%
Antiphospholipid Syndrome
13%
Lupus Anticoagulant
13%
Kounis Syndrome
13%
Personal Experience
13%
Screening Test
13%
Pain Assessment
13%
Diagnostic Accuracy
13%
Isotopes of Calcium
13%
Traumatic Brain Injury
13%
Ciprofloxacin
13%
Exome Sequencing
13%